Home/Filings/4/0001415889-17-000472
4//SEC Filing

Echo Therapeutics, Inc. 4

Accession 0001415889-17-000472

CIK 0001031927operating

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 3:57 PM ET

Size

7.3 KB

Accession

0001415889-17-000472

Insider Transaction Report

Form 4
Period: 2017-03-21
SCHOENBART ALAN WAYNE
CFO AND SECRETARY
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-03-21+500,000500,000 total
    Exercise: $0.16From: 2017-03-21Exp: 2027-03-21Common Stock (500,000 underlying)
  • Award

    Common Stock, par value $.01

    2017-03-21+100,000174,500 total
Footnotes (2)
  • [F1]Restricted shares granted pursuant to the Issuer's 2008 Equity Incentive Plan which vest in full on the date of grant.
  • [F2]Granted pursuant to the Issuer's 2008 Equity Incentive Plan.

Issuer

Echo Therapeutics, Inc.

CIK 0001031927

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001031927

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 3:57 PM ET
Size
7.3 KB